Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

Hillhouse Capital Advisors

Multi-Strategy
Manager
Hillhouse Capital Advisors
Quarter
Q2 2026
13F value
$832.1M
Positions
35
CIK
0001762304
SHARE:XLINKEDINEMAIL
Weights are % of 13F book — no reported capital figure for this filer.i
Legend Biotech CorpLEGNHISTORY20.77%—
Futu Hldgs LTDFUTUHISTORY19.92%+24.6%
Arrivent Biopharma IncAVBPHISTORY16.40%—
Marvell Technology IncMRVLHISTORY5.83%(4.7%)
Vipshop Hldgs LTDVIPSHISTORY5.53%+2,683.0%
PDD Holdings IncPDDHISTORY4.58%(88.0%)
Ke Hldgs IncBEKEHISTORY3.87%(47.6%)
Cytek Biosciences IncCTKBHISTORY3.54%—
Alamar Biosciences IncALMRHISTORY3.11%NEW
Alibaba Group Hldg LTDBABAHISTORY2.12%(92.5%)
Odyssey Therapeutics IncODTXHISTORY1.87%NEW
Yatsen Hldg LTDYSGHISTORY1.86%—
Novabridge BiosciencesNBPHISTORY1.40%—
Contineum Therapeutics IncCTNMHISTORY1.32%—
Maze Therapeutics IncMAZEHISTORY1.31%—
Agora IncAPIHISTORY1.01%—
Taiwan Semiconductor ManufacTSMHISTORY0.89%(0.1%)
Sagimet Biosciences IncSGMTHISTORY0.67%—
Netease Com IncNTESHISTORY0.54%NEW
GE AerospaceGEHISTORY0.45%—
Lumentum Hldgs IncLITEHISTORY0.34%+120.0%
Nvidia CorporationNVDAHISTORY0.34%+112.6%
Tuya IncTUYAHISTORY0.33%—
Corning IncGLWHISTORY0.32%+33.3%
Coherent CorpCOHRHISTORY0.30%+50.1%
Webull CorpBULLHISTORY0.24%(79.3%)
Intel CorpINTCHISTORY0.24%(50.6%)
Pacific Biosciences Calif InPACBHISTORY0.19%—
Texas Instrs IncTXNHISTORY0.17%NEW
Mogu IncMOGUHISTORY0.17%—
Gossamer Bio IncGOSSHISTORY0.10%—
Equinox Gold CorpEQXHISTORY0.09%—
Zoom Communications IncZMHISTORY0.09%NEW
Aligos Therapeutics IncALGSHISTORY0.05%—
Ridgetech IncRDGTHISTORY<0.01%NEW
Positions are from the latest 13F-HR (period end 2026-06-30). Weights are calculated: position value ÷ the 13F book. Schedule 13D/13G stakes are merged in when present (shares and percent of class, no dollar value). Chg Shares and % Chg compare with the adjacent prior quarter's 13F only. % Out is either calculated (position shares ÷ issuer shares outstanding from the issuer's XBRL cover page; weighted-average basic shares as a fallback) or reported (percent of class on a Schedule 13D/13G newer than the 13F period) — hover a value for its source and date. Unavailable figures show “—”, never an estimate. Methodology